methylphenidate modified release tablet - 8 hrs acting / Generic mfg.  >>  Phase 4
Welcome,         Profile    Billing    Logout  

3 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
methylphenidate modified release tablet - 8 hrs acting / Generic mfg.
NCT01393574: Comparing Treatment With Melatonin to Treatment With Stimulants (Methylphenidate) in Children With Attention Deficit Hyperactivity Disorder and Sleep Difficulties

Unknown status
4
46
RoW
Melatonin, Methylphenidate, Ritalin, Ritalin SR, Ritalin LA, Concerta
Assaf-Harofeh Medical Center
Attention Deficit Hyperactivity Disorder, Sleep Onset Insomnia
06/12
 
NCT02063945: Methylphenidate vs. Risperidone for the Treatment of Children and Adolescents With ADHD and Disruptive Disorders

Terminated
4
5
RoW
Methylphenidate, Ritalin, Ritalin SR, Ritalin LA, Concerta, Risperidone, Risperdal
Sheba Medical Center
Attention Deficit/Hyperactivity Disorder, Oppositional Defiant Disorder, Conduct Disorder
02/18
02/18
NCT00863499 / 2009-013272-47: International Study to Predict Optimised Treatment in Attention Deficit/Hyperactivity Disorder

Unknown status
4
1344
Europe, US, RoW
Short Acting Methylphenidate, • Ritalin, • Ritalina, • Attenta, • Methylin, • Penid, • Rubifen, *Consider treatment directions above or as physician directed as per usual care., Long Acting Methylphenidate, • Concerta, • Metadate CD, • Methylin ER, • Ritalin LA, • Ritalin Sustained-Release
BRC Operations Pty. Ltd.
Attention Deficit/Hyperactivity Disorder
12/19
12/19

Download Options